MSB 1.73% $1.18 mesoblast limited

SI's summary of the Covid ARDS trial seems to confirm what I...

  1. 102 Posts.
    lightbulb Created with Sketch. 252
    SI's summary of the Covid ARDS trial seems to confirm what I surmised - that instead of fewer people dying in the latter stages of the trial as many have claimed, pretty much everyone died.
    This is because the requirement for inclusion of a patient into the trial was that they were on ventilation, and SoC changed after July 2020 so that ventilation was avoided (slowing trial enrolment) or severely delayed (leading to very ill patients that were near death). This matches all the available data we have and provides a reason why enrolment slowed down.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.18
Change
0.020(1.73%)
Mkt cap ! $1.341B
Open High Low Value Volume
$1.20 $1.21 $1.17 $16.67M 14.04M

Buyers (Bids)

No. Vol. Price($)
5 54704 $1.18
 

Sellers (Offers)

Price($) Vol. No.
$1.18 10000 1
View Market Depth
Last trade - 16.10pm 07/05/2024 (20 minute delay) ?
Last
$1.19
  Change
0.020 ( 3.40 %)
Open High Low Volume
$1.21 $1.21 $1.17 2927691
Last updated 15.59pm 07/05/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.